Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BCBA/MRNA stock hub

BCBA/MRNA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/MRNAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/MRNA

In the news

Latest news · BCBA/MRNA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-36.6

P25 n/aP50 n/aP75 n/a

ROIC-66.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/MRNA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

USD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	4,700
Employees Change	-1,100%
Employees Change Percent	-18.97
Enterprise value	ARS 21.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	ARS 30T
Price	ARS 4,208
Price currency	ARS
Rev Per Employee	654,014,464.36x
Sic	2836
Symbol	bcba/MRNA
Website	https://www.modernatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.69%
EV Earnings	-4.86x
EV/FCF	-9.69x
EV/Sales	6.92x
FCF yield	-7.37%
P/B ratio	2.93x
P/S ratio	9.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-113.89%
EBITDA Margin	-103.33%
Gross margin	-69.89%
Gross Profit	ARS -2.1T
Net Income	ARS -4.4T
Pretax Margin	-141.03%
Profit Margin	-143.55%
Profit Per Employee	ARS -938.8M
ROA	-13.09
Roa5y	6.72
ROCE	-27.87
ROE	-36.56
Roe5y	22.02
ROIC	-66.19
Roic5y	177.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	186.43%
Revenue Growth	-29.97x
Revenue Growth Q	260.19x
Revenue Growth3 Y	-47.13x
Revenue Growth5 Y	-4.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.18
Assets	ARS 15.9T
Cash	ARS 7.2T
Current Assets	ARS 8.1T
Current Liabilities	ARS 3.3T
Debt	ARS 1.8T
Debt Equity	ARS 0.18
Debt FCF	ARS -0.81
Equity	ARS 10.2T
Interest Coverage	-97.46
Liabilities	ARS 5.6T
Long Term Assets	ARS 7.8T
Long Term Liabilities	ARS 2.3T
Net Cash	ARS 8.5T
Net Cash By Market Cap	ARS 28.33
Net Cash Growth	-19.48%
Net Debt Equity	ARS -0.83
Tangible Book Value	ARS 10T
Tangible Book Value Per Share	ARS 25,194

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.41
Inventory Turnover	27.59
Net Working Capital	ARS -2.5T
Quick ratio	2.23
Working Capital	ARS 4.7T
Working Capital Turnover	ARS 720

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	186.22%
200-day SMA	2,765
50-day SMA	4,001.4
50-day SMA vs 200-day SMA	50over200
All Time High	11,150
All Time High Change	-62.26%
All Time High Date	2024-05-23
All Time Low	1,380
All Time Low Change	204.89%
All Time Low Date	2025-04-21
ATR	250.7
Ch YTD	69.86
High	4,520
High52	4,550
High52 Date	2026-03-04
High52ch	-7.53%
Low	3,882.5
Low52	1,420
Low52 Date	2025-05-15
Low52ch	196.3%
Ma50ch	5.15%
Price vs 200-day SMA	52.17%
RSI	59.64
RSI Monthly	38.77
RSI Weekly	67.18
Sharpe ratio	1.61x
Sortino ratio	2.81
Total Return	-1.62%
Tr YTD	69.86
Tr1m	7.4%
Tr1w	13.03%
Tr3m	33.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS -3.5T
Operating margin	-113.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	370,094,602%
Net Borrowing	811,221,591,860
Shares Insiders	6.64%
Shares Institutions	80.34%
Shares Qo Q	0.77%
Shares Yo Y	1.62%
Short Ratio	7.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS -2.9T
Average Volume	29,447.75x
Bv Per Share	25,779
CAPEX	ARS -189.3B
Ch1m	7.4
Ch1w	13.03
Ch1y	186.2
Ch3m	33.36
Ch6m	124.3
Change	11.68%
Change From Open	6.99
Close	3,767.5
Days Gap	4.38
Depreciation Amortization	328,684,610,495
Dollar Volume	728,511,795
Earnings Date	2026-05-01
EBIT	ARS -3.5T
EBITDA	ARS -3.2T
EPS	ARS -11,278
F Score	2
FCF	ARS -2.2T
FCF EV Yield	-10.32x
Financing CF	837,197,302,200
Fiscal Year End	December
Founded	2,010
Goodwill	72,730,211,684
Income Tax	ARS 77.4B
Investing CF	1,574,925,618,000
Is Primary Listing	0
Last Earnings Date	2026-05-01
Last Report Date	2026-03-31
Ma150	3,036.6
Ma150ch	38.56%
Ma20	3,952.3
Ma20ch	6.46%
Net CF	390,968,377,100
Open	3,932.5
Position In Range	50.98
Ppne	3,905,052,904,264
Price Date	2026-05-08
Ptbv Ratio	3
Relative Volume	5.88x
Revenue	3,073,867,982,500x
SBC By Revenue	21.21x
Share Based Comp	652,074,466,400
Tax By Revenue	2.52x
Tr6m	124.28%
Volume	173,146
Z Score	2.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BCBA/MRNA pay a dividend?

Capital-return profile for this ticker.

Performance

BCBA/MRNA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/MRNA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.3%

Share of float held by funds and institutions

Insider ownership

+6.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/MRNA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.6

Neutral momentum band

Price vs 200-day MA

+52.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/MRNA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/MRNA stock rating?

bcba/MRNA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/MRNA analysis?

The full report lives at /stocks/bcba/MRNA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/MRNA?

The latest report frames bcba/MRNA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/MRNA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.